Portfolio company
Kano Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company manufactures circular single-stranded DNA templates for biotechnology and pharmaceutical partners to enable gene insertions in cell and gene therapy.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kano
This biotechnology company develops and manufactures circular single-stranded DNA templates to improve the delivery of gene therapies for medical research and pharmaceutical partners.
Artis BioSolutions
The company produces synthetic DNA and manufacturing services for biotechnology and pharmaceutical firms developing genetic medicines and advanced therapies.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Kamau Therapeutics
This company develops clinical-stage gene correction therapies using targeted DNA integration to treat patients with sickle cell disease and other genetic conditions.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
Anjarium BioSciences
This company develops non-viral gene therapies and synthetic DNA vectors for patients with genetic diseases and life sciences researchers.
EnPlusOne
This company develops enzymatic RNA synthesis technology for biotechnology firms and pharmaceutical manufacturers to produce oligonucleotides for therapeutic applications.
Ansa Biotechnologies
This company manufactures synthetic DNA using enzymatic synthesis technology for researchers in biological engineering, therapeutics, diagnostics and agriculture.
